1309, 2018

Focus AIM: 4 September

Settembre 13th, 2018|Commenti disabilitati su Focus AIM: 4 September

MILAN (AIMnews.it) - The total traded turnover today is equal to 12,170,577 euros; the FTSE AIM Italia recorded a performance of + 0.34% to 9,401.49 points, the FTSE Italia PIR PMI All with + 0.13%. [...]

1309, 2018

GPI: buy-back program begins

Settembre 13th, 2018|Commenti disabilitati su GPI: buy-back program begins

MILANO (AIMnews.it) - The Board of Directors of GPI have approved the launch of a new program for the purchase of treasury shares - active from today until October 30th, 2019 - for various purposes. [...]

1309, 2018

Elettra Investimenti: buy-back continues

Settembre 13th, 2018|Commenti disabilitati su Elettra Investimenti: buy-back continues

MILANO (AIMnews.it) - From 27th to 31th of August Elettra Investimenti purchased 500 treasury shares, equal to 0.01303% of the current share capital, at an average unit price of € 10 per share. To date, [...]

1309, 2018

Zephyro: share capital rises to 1.2 mln after warrant exercise

Settembre 13th, 2018|Commenti disabilitati su Zephyro: share capital rises to 1.2 mln after warrant exercise

MILANO (AIMnews.it) - In September the exercise ratio of Zephyro S.p.A. Warrants is 0.1523, a figure taken from the average monthly price of August, which is equal to 10.2455 euros, and the strike price, which [...]

1309, 2018

Equita: VI investimento fondo private debt al fianco di L Catterton e Ambienta

Settembre 13th, 2018|Commenti disabilitati su Equita: VI investimento fondo private debt al fianco di L Catterton e Ambienta

MILANO (AIMnews.it) – L’operazione ha portato all’acquisizione di Pibiplast. Equita ha affiancato i due fondi sottoscrivendo per intero un prestito obbligazionario subordinato di 10 milioni di euro emesso dal veicolo d’investimento controllato dagli stessi fondi di private equity.

1309, 2018

BioDue, purchase of its own shares

Settembre 13th, 2018|Commenti disabilitati su BioDue, purchase of its own shares

MILANO (AIMnews.it) - Last week BioDue purchased 5.000 of its own shares, equal to about 0.04485% of the share capital, at an average price of 5.29 euro per share. As of August 31st, the company [...]